These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6380229)

  • 21. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
    Syrek M; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 1997; 49(6):453-62. PubMed ID: 9566049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy of depression: benefits and limits of blood levels of tricyclic antidepressants].
    Baumann P
    Schweiz Med Wochenschr; 1981 Feb; 111(7):228-39. PubMed ID: 7013064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
    Danie WA; Syrek M; Ryłko Z; Wójcikowski J
    Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation.
    Mellström B; Bertilsson L; Säwe J; Schulz HU; Sjöqvist F
    Clin Pharmacol Ther; 1981 Aug; 30(2):189-93. PubMed ID: 7249504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant properties of trazodone.
    Bryant SG; Ereshefsky L
    Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin.
    Baumann P; Jonzier-Perey M; Koeb L; Küpfer A; Tinguely D; Schöpf J
    Int Clin Psychopharmacol; 1986 Apr; 1(2):102-12. PubMed ID: 3571939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics.
    Cutler NR; Narang PK
    Psychiatr Clin North Am; 1984 Dec; 7(4):845-61. PubMed ID: 6441158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic monitoring of tricyclic antidepressant drugs].
    Grzesiak M; Beszłej JA; Szewczuk-Bogusławska M
    Psychiatr Pol; 2003; 37(5):825-37. PubMed ID: 14631602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcome.
    Papakostas GI; Petersen T; Pava J; Masson E; Worthington JJ; Alpert JE; Fava M; Nierenberg AA
    J Nerv Ment Dis; 2003 Jul; 191(7):444-9. PubMed ID: 12891091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prediction of tricyclic antidepressant plasma concentrations.
    Braithwaite RA; Dawling S; Montgomery SA; McAuley R
    Postgrad Med J; 1980; 56 Suppl 1():112-4. PubMed ID: 7393819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of amitriptyline: effect of age and sex.
    Preskorn SH; Mac DS
    J Clin Psychiatry; 1985 Jul; 46(7):276-7. PubMed ID: 4008451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation.
    Mellström B; Bertilsson L; Lou YC; Säwe J; Sjöqvist F
    Clin Pharmacol Ther; 1983 Oct; 34(4):516-20. PubMed ID: 6617075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.